Literature DB >> 32118808

Hearing Preservation Outcomes and Prognostic Factors in Acoustic Neuroma Surgery: Predicting Cutoffs.

Elisabetta Zanoletti1, Antonio Mazzoni1, Anna Chiara Frigo2, Daniele Borsetto2, Diego Cazzador1,3.   

Abstract

OBJECTIVE: To investigate the outcomes of hearing preservation surgery (HPS) for acoustic neuroma and quantify tumor and patient characteristics predictive of hearing preservation after surgery. STUDY
DESIGN: Retrospective study.
SETTING: Tertiary referral center. PATIENTS: A total of 100 consecutive patients diagnosed with acoustic neuroma from 2000 to 2012. INTERVENTION: Hearing preservation surgery through microscopic retrosigmoid approach combined with a retrolabyrinthine meatotomy. MAIN OUTCOME MEASURE: Pre- and postoperative hearing stratified according to the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) and the Tokyo classifications. The most accurate cutoff was identified for each tumor and patients' variable affecting the outcome by calculating the Youden index. A multivariable analysis was undertaken at these cutoffs to identify prognostic factors for hearing preservation.
RESULTS: Preoperative hearing class was preserved after surgery in 31% (AAO-HNS), and 39% (Tokyo classification) of patients. According to the AAO-HNS classification, the tumor size in the cerebello-pontine angle, pure-tone average (PTA), and speech discrimination score cutoffs for predicting good postoperative hearing function were 7 mm, 21 dB, and 90%, respectively. With the Tokyo classification, only the PTA cutoff differed, with 27 dB. On multivariable analysis, tumor size and PTA were independent prognostic factors for postoperative hearing with high model's goodness of fit (area under the curve  = 0.784; 95% CI = 0.68-0.88 and area under the curve  = 0.813; 95% CI = 0.72-0.90), according to both the hearing classifications.
CONCLUSIONS: The estimated cutoffs for tumor size and PTA were independently associated with HPS. These factors should be prospectively investigated before they are adopted as selection criteria for HPS.

Entities:  

Mesh:

Year:  2020        PMID: 32118808     DOI: 10.1097/MAO.0000000000002602

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  4 in total

1.  Cochlear implant in vestibular schwannomas: long-term outcomes and critical analysis of indications.

Authors:  Flavia Sorrentino; Giulia Tealdo; Diego Cazzador; Niccolò Favaretto; Davide Brotto; Silvia Montino; Ezio Caserta; Roberto Bovo; Luca Denaro; Valentina Baro; Domenico D'Avella; Alessandro Martini; Antonio Mazzoni; Gino Marioni; Elisabetta Zanoletti
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-01-12       Impact factor: 3.236

Review 2.  Understanding the Molecular Mechanism of Vestibular Schwannoma for Hearing Preservation Surgery: Otologists' Perspective from Bedside to Bench.

Authors:  Makoto Hosoya; Takeshi Wakabayashi; Koichiro Wasano; Takanori Nishiyama; Nobuyoshi Tsuzuki; Naoki Oishi
Journal:  Diagnostics (Basel)       Date:  2022-04-21

3.  Defining current practice patterns of vestibular schwannoma management in Italy: results of a nationwide survey.

Authors:  Diego Cazzador; Elisabetta Zanoletti; Nicola Quaranta; Marco Pontrelli; Sabino Ciprelli; Francesco Signorelli; Luca Denaro; Domenico d'Avella; Giovanni Danesi
Journal:  Acta Otorhinolaryngol Ital       Date:  2021-04       Impact factor: 2.124

4.  Applicability of contemporary quality indicators in vestibular surgery-do they accurately measure tumor inherent postoperative complications of vestibular schwannomas?

Authors:  Stephanie Schipmann; Sebastian Lohmann; Bilal Al Barim; Eric Suero Molina; Michael Schwake; Özer Altan Toksöz; Walter Stummer
Journal:  Acta Neurochir (Wien)       Date:  2021-12-02       Impact factor: 2.216

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.